<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04611295</url>
  </required_header>
  <id_info>
    <org_study_id>942/2020/DISP/AOUMO</org_study_id>
    <nct_id>NCT04611295</nct_id>
  </id_info>
  <brief_title>TELENeurological Support for Emergency Department</brief_title>
  <acronym>TELENS-ED</acronym>
  <official_title>TELENeurological Evaluation and Support for the Emergency Department (TELENS-ED): an Open-label Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria di Modena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda USL Modena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria di Modena</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label, non-inferiority, teleconsultation with televisit study to compare efficacy,&#xD;
      safety and users satisfaction of a TeleNeurological Support versus &quot;in person&quot; neurological&#xD;
      examination in the emergency department&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigtors are going to perform an interventional, open-label study on the use of&#xD;
      teleconsultation in the emergency department focused on neurological diseases other than&#xD;
      stroke (for which a specific protocol already exists) in two Hospitals of Modena province,&#xD;
      Italy.&#xD;
&#xD;
      The study is aimed at developing a remote neurological consultancy system (teleconsultation)&#xD;
      for patients with acute neurological symptoms in charge of hospital facilities without&#xD;
      24-hour availability of neurologist consultant.&#xD;
&#xD;
      Pilot project setting: a) ED of Modena Policlinico Hospital in the afternoon, night, and&#xD;
      public holidays, time windows in which the Neurologist consultant is not present at&#xD;
      Policlinico Hospital; b) ED of Mirandola Hospital.&#xD;
&#xD;
      The project (enrolment) is expected to be developed over a period of 6 months in which 100&#xD;
      patients will be enrolled.&#xD;
&#xD;
      The primary objective is to assess whether a TeleNeurological Evaluation and Support for the&#xD;
      Emergency Department can guarantee a faster but qualitatively not inferior&#xD;
      diagnostic/therapeutic work-up if compared with in person examination, assuring the&#xD;
      availability of all the necessary examinations and treatments with a consistent time&#xD;
      reduction.&#xD;
&#xD;
      Secondary objectives: to determine if the usage of a teleconsultation physician for&#xD;
      neurological evaluation compared to a conventional physician &quot;de visu&quot; in urgent but&#xD;
      non-life-threatening neurological cases, is superior regarding 1) effect evaluation, 2)&#xD;
      process evaluation, and 3) cost-benefit analysis.&#xD;
&#xD;
      Outcome and process indicators will be assessed and compared in the following groups:&#xD;
&#xD;
        -  Experimental group (cases): a) patients who access the Policlinico Hospital ED in the&#xD;
           afternoon and night-time and on holidays; b) patients who access the Mirandola Hospital&#xD;
           ED during the period of the study.&#xD;
&#xD;
        -  Control Groups: a) retrospectively collected data on neurological consultation performed&#xD;
           by OCB Neurology for Policlinico Hospital patients in the same time slots in the same&#xD;
           months of the last two years.; b) retrospectively collected data on neurological&#xD;
           consultation performed by Carpi Neurology for Mirandola Hospital patients in the same&#xD;
           time slots in the same months of the last two years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">October 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Teleconsultation clinical application</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of patients who undergo neurological teleconsultation over the number of patients who access on the days and in the time slots in which the service is active and needing a neurological evaluation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Teleconsultation diagnostic efficacy</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of patients re-admitted to the ED in the 7 days following the date of neurological consultation. It is expected that for the patients of the neurological teleconsultation the % of re-admission to ED will not exceed that of the patients undergone standard neurological advice.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Teleconsultation efficacy - hospitalization</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of hospitalized patients among those undergone TeleNeurology compared to percentage of hospitalization for patients with in person neurological evaluation. It is expected that for patients of the teleneurology group the % of hospitalization will not exceed that of patients undergone standard neurological advice.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time 'door to end of diagnostic process'</measure>
    <time_frame>6 months</time_frame>
    <description>The total time from ED admission to the end of the diagnostic and therapeutic process (time spent in the ED): this time is expected to be significantly shorter for patients in the teleneurology group than for patients having a standard neurological advice.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time 'door to end of neurological evaluation'</measure>
    <time_frame>6 months</time_frame>
    <description>The time from the ED admission to the end of the remote neurological consultation: this time is expected to be significantly shorter for patients in the teleneurology group than for patients having a standard neurological advice</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of costs, or cost-effectiveness. For the evaluation of costs, it will be developed a model that considers the cost of the system on the one hand, and the savings in terms of personnel (medical personnel, paramedics and ambulances costs). Outcome indicator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the level of satisfaction of the users</measure>
    <time_frame>6 months</time_frame>
    <description>For this purpose an evaluation form will be provided to patients / family members. Users satisfaction will be measured by visual analogue scale (VAS) where 100 is the highest satisfaction and 0 is the lowest. Outcome indicator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the level of satisfaction of the health personnel.</measure>
    <time_frame>6 months</time_frame>
    <description>For this purpose an evaluation form will be provided to medical personnel involved. Personnel satisfaction will be measured by visual analogue scale (VAS) where 100 is the highest satisfaction and 0 is the lowest. Outcome indicator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Teleconsultation failure</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of cases assessed by teleconsultation for which the neurologist was unable to make remote decisions and requested for sending the patient to Hub Hospital for a &quot;first-person&quot; evaluation. Process indicator.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Emergencies</condition>
  <condition>Neurologic Disorder</condition>
  <arm_group>
    <arm_group_label>Teleneurological evaluation and support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>teleneurological evaluation using a medical device certified as telemedicine system</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Teleneurological evaluation and support</intervention_name>
    <description>The study is aimed at developing a remote neurological consultancy system (teleconsultation) for patients with acute neurological symptoms in charge of hospital facilities without 24-hour availability of neurologist consultant.</description>
    <arm_group_label>Teleneurological evaluation and support</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged &gt; 18 years&#xD;
&#xD;
          -  Symptoms related to possible acute / subacute neurological pathology, or worsening of&#xD;
             known neurological pathology, for which the ED physician considers neurological&#xD;
             consultation indicated / necessary.&#xD;
&#xD;
          -  Signing of informed consent to remote neurological evaluation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All life-threatening emergency cases, where the study procedure would interfere with&#xD;
             clinical practice&#xD;
&#xD;
          -  Patients with known neurological pathology or with clinical severity to such an extent&#xD;
             that the need for admission to OCB/Carpi Neurology unit or to the internal wards of&#xD;
             the Policlinico is immediately evident.&#xD;
&#xD;
          -  Refusal of the patient/caregiver to perform remote neurological evaluation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Luciani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero Universitaria Policlinico Modena</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefano Meletti, Prof, MD</last_name>
    <phone>+390593962546</phone>
    <email>meletti.stefano@aou.mo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica Mandrioli, MD</last_name>
    <phone>+390593961640</phone>
    <email>mandrioli.jessica@aou.mo.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Azienda USL di Modena</name>
      <address>
        <city>Modena</city>
        <zip>41123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mario Santangelo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria di Modena</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Meletti</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Piano per il miglioramento dell'accesso in Emergenza Urgenza nelle strutture sanitarie dell'Emilia-Romagna; https://bur.regione.emilia-romagna.it/dettaglio-inserzione?i=7b644492dfe2471787f041d37a19f2e8; 24.07.2019</citation>
  </reference>
  <reference>
    <citation>WHO. A health telematics policy in support of WHO's Health-For-All strategy for global health development: report of the WHO group consultation on health telematics, 11-16 December, Geneva, 1997. Geneva, World Health Organization, 1998.).</citation>
  </reference>
  <reference>
    <citation>Bove AA, Homko CJ, Santamore WP, Kashem M, Kerper M, Elliott DJ. Managing hypertension in urban underserved subjects using telemedicine--a clinical trial. Am Heart J. 2013 Apr;165(4):615-21. doi: 10.1016/j.ahj.2013.01.004. Epub 2013 Mar 6.</citation>
    <PMID>23537980</PMID>
  </reference>
  <reference>
    <citation>Verhoeven F, van Gemert-Pijnen L, Dijkstra K, Nijland N, Seydel E, Steehouder M. The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review. J Med Internet Res. 2007 Dec 14;9(5):e37. Review.</citation>
    <PMID>18093904</PMID>
  </reference>
  <reference>
    <citation>Brebner JA, Brebner EM, Ruddick-Bracken H. Accident and emergency teleconsultation for primary care--a systematic review of technical feasibility, clinical effectiveness, cost effectiveness and level of local management. J Telemed Telecare. 2006;12 Suppl 1:5-8. Review.</citation>
    <PMID>16884562</PMID>
  </reference>
  <reference>
    <citation>Hersh W, Helfand M, Wallace J, Kraemer D, Patterson P, Shapiro S, Greenlick M. A systematic review of the efficacy of telemedicine for making diagnostic and management decisions. J Telemed Telecare. 2002;8(4):197-209. Review.</citation>
    <PMID>12217102</PMID>
  </reference>
  <reference>
    <citation>Hersh WR, Hickam DH, Severance SM, Dana TL, Pyle Krages K, Helfand M. Diagnosis, access and outcomes: Update of a systematic review of telemedicine services. J Telemed Telecare. 2006;12 Suppl 2:S3-31. Review.</citation>
    <PMID>16989671</PMID>
  </reference>
  <reference>
    <citation>Deldar K, Bahaadinbeigy K, Tara SM. Teleconsultation and Clinical Decision Making: a Systematic Review. Acta Inform Med. 2016 Jul 16;24(4):286-292.</citation>
    <PMID>27708494</PMID>
  </reference>
  <reference>
    <citation>Nerlich M, Balas EA, Schall T, Stieglitz SP, Filzmaier R, Asbach P, Dierks C, Lacroix A, Watanabe M, Sanders JH, Doarn CR, Merrell RC; G8 Global Health Applications Subproject 4. Teleconsultation practice guidelines: report from G8 Global Health Applications Subproject 4. Telemed J E Health. 2002 Winter;8(4):411-8.</citation>
    <PMID>12626110</PMID>
  </reference>
  <reference>
    <citation>Epstein RM. Communication between primary care physicians and consultants. Arch Fam Med. 1995 May;4(5):403-9.</citation>
    <PMID>7742962</PMID>
  </reference>
  <reference>
    <citation>Belyansky I, Martin TR, Prabhu AS, Tsirline VB, Howley LD, Phillips R, Sindram D, Heniford BT, Stefanidis D. Poor resident-attending intraoperative communication may compromise patient safety. J Surg Res. 2011 Dec;171(2):386-94. doi: 10.1016/j.jss.2011.04.011. Epub 2011 May 6.</citation>
    <PMID>21601875</PMID>
  </reference>
  <reference>
    <citation>Audebert HJ, Kukla C, Clarmann von Claranau S, Kühn J, Vatankhah B, Schenkel J, Ickenstein GW, Haberl RL, Horn M; TEMPiS Group. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke. 2005 Feb;36(2):287-91. Epub 2004 Dec 29.</citation>
    <PMID>15625294</PMID>
  </reference>
  <reference>
    <citation>Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL; Telemedic Pilot Project for Integrative Stroke Care Group. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol. 2006 Sep;5(9):742-8.</citation>
    <PMID>16914402</PMID>
  </reference>
  <reference>
    <citation>Audebert HJ, Schultes K, Tietz V, Heuschmann PU, Bogdahn U, Haberl RL, Schenkel J; Telemedical Project for Integrative Stroke Care (TEMPiS). Long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical Project for Integrative Stroke Care (TEMPiS). Stroke. 2009 Mar;40(3):902-8. doi: 10.1161/STROKEAHA.108.529255. Epub 2008 Nov 20.</citation>
    <PMID>19023095</PMID>
  </reference>
  <reference>
    <citation>Demaerschalk BM, Bobrow BJ, Raman R, Kiernan TE, Aguilar MI, Ingall TJ, Dodick DW, Ward MP, Richemont PC, Brazdys K, Koch TC, Miley ML, Hoffman Snyder CR, Corday DA, Meyer BC; STRokE DOC AZ TIME Investigators. Stroke team remote evaluation using a digital observation camera in Arizona: the initial mayo clinic experience trial. Stroke. 2010 Jun;41(6):1251-8. doi: 10.1161/STROKEAHA.109.574509. Epub 2010 Apr 29.</citation>
    <PMID>20431081</PMID>
  </reference>
  <reference>
    <citation>Handschu R, Scibor M, Willaczek B, Nückel M, Heckmann JG, Asshoff D, Belohlavek D, Erbguth F, Schwab S; STENO Project. Telemedicine in acute stroke: remote video-examination compared to simple telephone consultation. J Neurol. 2008 Nov;255(11):1792-7. doi: 10.1007/s00415-008-0066-9. Epub 2008 Dec 8.</citation>
    <PMID>19156491</PMID>
  </reference>
  <reference>
    <citation>Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, Thomas RG, Lyden PD. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol. 2008 Sep;7(9):787-95. doi: 10.1016/S1474-4422(08)70171-6.</citation>
    <PMID>18676180</PMID>
  </reference>
  <reference>
    <citation>Sejersten M, Sillesen M, Hansen PR, Nielsen SL, Nielsen H, Trautner S, Hampton D, Wagner GS, Clemmensen P. Effect on treatment delay of prehospital teletransmission of 12-lead electrocardiogram to a cardiologist for immediate triage and direct referral of patients with ST-segment elevation acute myocardial infarction to primary percutaneous coronary intervention. Am J Cardiol. 2008 Apr 1;101(7):941-6. doi: 10.1016/j.amjcard.2007.11.038. Epub 2008 Jan 25.</citation>
    <PMID>18359312</PMID>
  </reference>
  <reference>
    <citation>Chua R, Craig J, Wootton R, Patterson V. Randomised controlled trial of telemedicine for new neurological outpatient referrals. J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):63-6.</citation>
    <PMID>11413265</PMID>
  </reference>
  <reference>
    <citation>Skorning M, Bergrath S, Rörtgen D, Brokmann JC, Beckers SK, Protogerakis M, Brodziak T, Rossaint R. [E-health in emergency medicine - the research project Med-on-@ix]. Anaesthesist. 2009 Mar;58(3):285-92. doi: 10.1007/s00101-008-1502-z. German.</citation>
    <PMID>19221700</PMID>
  </reference>
  <reference>
    <citation>Ziegler V, Rashid A, Müller-Gorchs M, Kippnich U, Hiermann E, Kögerl C, Holtmann C, Siebler M, Griewing B. [Mobile computing systems in preclinical care of stroke. Results of the Stroke Angel initiative within the BMBF project PerCoMed]. Anaesthesist. 2008 Jul;57(7):677-85. doi: 10.1007/s00101-008-1395-x. German.</citation>
    <PMID>18542893</PMID>
  </reference>
  <reference>
    <citation>Tso JV, Farinpour R, Chui HC, Liu CY. A Multidisciplinary Model of Dementia Care in an Underserved Retirement Community, Made Possible by Telemedicine. Front Neurol. 2016 Dec 23;7:225. doi: 10.3389/fneur.2016.00225. eCollection 2016.</citation>
    <PMID>28066313</PMID>
  </reference>
  <reference>
    <citation>Rasmusson KA, Hartshorn JC. A comparison of epilepsy patients in a traditional ambulatory clinic and a telemedicine clinic. Epilepsia. 2005 May;46(5):767-70.</citation>
    <PMID>15857445</PMID>
  </reference>
  <reference>
    <citation>Müller KI, Alstadhaug KB, Bekkelund SI. A randomized trial of telemedicine efficacy and safety for nonacute headaches. Neurology. 2017 Jul 11;89(2):153-162. doi: 10.1212/WNL.0000000000004085. Epub 2017 Jun 14.</citation>
    <PMID>28615434</PMID>
  </reference>
  <reference>
    <citation>Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S, Miller D, Reminick JI, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Biglan KM. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord. 2010 Aug 15;25(11):1652-9. doi: 10.1002/mds.23145.</citation>
    <PMID>20533449</PMID>
  </reference>
  <reference>
    <citation>AAN Recommendations for Expanded Coverage of Telemedicine Services. Updated on 1st July, 2020. https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist--administrators/practice-top-5/aan-comments-to-cms-telemed-coverage.pdf</citation>
  </reference>
  <reference>
    <citation>Cohen BH, Busis NA, Ciccarelli L. Coding in the World of COVID-19: Non-Face-to-Face Evaluation and Management Care. Continuum (Minneap Minn). 2020 Jun;26(3):785-798. doi: 10.1212/CON.0000000000000874.</citation>
    <PMID>32487907</PMID>
  </reference>
  <reference>
    <citation>George BP, Kelly AG. Rethinking Regional Neurologic Care in the Coronavirus Disease 2019 Era. JAMA Neurol. 2020 Sep 1;77(9):1061-1062. doi: 10.1001/jamaneurol.2020.1956. Review.</citation>
    <PMID>32597937</PMID>
  </reference>
  <reference>
    <citation>von Oertzen TJ, Macerollo A, Leone MA, Beghi E, Crean M, Oztuk S, Bassetti C, Twardzik A, Bereczki D, Di Liberto G, Helbok R, Oreja-Guevara C, Pisani A, Sauerbier A, Sellner J, Soffietti R, Zedde M, Bianchi E, Bodini B, Cavallieri F, Campiglio L, Maia LF, Priori A, Rakusa M, Taba P, Moro E, Jenkins TM; EANcore COVID-19 task force. EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol. 2021 Jan;28(1):7-14. doi: 10.1111/ene.14521. Epub 2020 Oct 15. Review.</citation>
    <PMID>33058321</PMID>
  </reference>
  <reference>
    <citation>Dorsey ER, Topol EJ. State of Telehealth. N Engl J Med. 2016 Jul 14;375(2):154-61. doi: 10.1056/NEJMra1601705. Review.</citation>
    <PMID>27410924</PMID>
  </reference>
  <reference>
    <citation>Czeisler MÉ, Marynak K, Clarke KEN, Salah Z, Shakya I, Thierry JM, Ali N, McMillan H, Wiley JF, Weaver MD, Czeisler CA, Rajaratnam SMW, Howard ME. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257. doi: 10.15585/mmwr.mm6936a4.</citation>
    <PMID>32915166</PMID>
  </reference>
  <reference>
    <citation>Lange SJ, Ritchey MD, Goodman AB, Dias T, Twentyman E, Fuld J, Schieve LA, Imperatore G, Benoit SR, Kite-Powell A, Stein Z, Peacock G, Dowling NF, Briss PA, Hacker K, Gundlapalli AV, Yang Q. Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions - United States, January-May 2020. MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):795-800. doi: 10.15585/mmwr.mm6925e2.</citation>
    <PMID>32584802</PMID>
  </reference>
  <reference>
    <citation>Teo KC, Leung WCY, Wong YK, Liu RKC, Chan AHY, Choi OMY, Kwok WM, Leung KK, Tse MY, Cheung RTF, Tsang AC, Lau KK. Delays in Stroke Onset to Hospital Arrival Time During COVID-19. Stroke. 2020 Jul;51(7):2228-2231. doi: 10.1161/STROKEAHA.120.030105. Epub 2020 May 20.</citation>
    <PMID>32432998</PMID>
  </reference>
  <reference>
    <citation>Keesara S, Jonas A, Schulman K. Covid-19 and Health Care's Digital Revolution. N Engl J Med. 2020 Jun 4;382(23):e82. doi: 10.1056/NEJMp2005835. Epub 2020 Apr 2.</citation>
    <PMID>32240581</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 27, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero-Universitaria di Modena</investigator_affiliation>
    <investigator_full_name>Stefano Meletti</investigator_full_name>
    <investigator_title>Study coordinator and Clinical Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will be available at study end</ipd_time_frame>
    <ipd_access_criteria>Upon request to principal investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

